$476 Million is the total value of AIGH Capital Management LLC's 101 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 51.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Sell | ISHARES TRput | $109,375,000 | -36.4% | 500,000 | -33.3% | 23.00% | -25.7% |
SIMO | New | SILICON MOTION TECHNOLOGY COsponsored adr | $29,117,000 | – | 1,468,735 | +100.0% | 6.12% | – |
EMKR | EMCORE CORP | $25,209,000 | -18.9% | 3,370,153 | 0.0% | 5.30% | -5.2% | |
PDFS | Buy | PDF SOLUTIONS INC | $23,156,000 | +41.5% | 1,005,000 | +11.7% | 4.87% | +65.3% |
PLAB | Buy | PHOTRONICS INC | $18,683,000 | +4.7% | 1,370,734 | +1.5% | 3.93% | +22.3% |
AVNW | AVIAT NETWORKS INC | $18,227,000 | +0.3% | 554,682 | 0.0% | 3.83% | +17.1% | |
BLIN | New | BRIDGELINE DIGITAL INC | $17,214,000 | – | 1,259,644 | +100.0% | 3.62% | – |
GRTX | Buy | GALERA THERAPEUTICS INC | $16,496,000 | -17.0% | 2,036,495 | +0.7% | 3.47% | -3.1% |
ADTN | New | ADTRAN INC | $15,246,000 | – | 812,656 | +100.0% | 3.21% | – |
OIIM | Buy | O2MICRO INTERNATIONAL LIMITEspons adr | $14,849,000 | +12.7% | 2,458,402 | +34.5% | 3.12% | +31.6% |
ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $12,696,000 | -1.3% | 2,585,743 | +6.2% | 2.67% | +15.3% |
AVEO | New | AVEO PHARMACEUTICALS INC | $12,275,000 | – | 1,986,176 | +100.0% | 2.58% | – |
THTX | Sell | THERATECHNOLOGIES INC | $11,962,000 | -16.4% | 3,023,036 | -15.5% | 2.52% | -2.3% |
DZSI | Sell | DZS INC | $11,880,000 | -47.0% | 969,015 | -10.3% | 2.50% | -38.1% |
PDSB | Sell | PDS BIOTECHNOLOGY CORP | $11,527,000 | -38.7% | 773,560 | -48.4% | 2.42% | -28.4% |
XFOR | Buy | X4 PHARMACEUTICALS INC | $8,805,000 | -5.9% | 1,664,540 | +15.7% | 1.85% | +10.0% |
SCPH | Buy | SCPHARMACEUTICALS INC | $8,207,000 | +109.1% | 1,234,121 | +92.2% | 1.73% | +144.5% |
PRTK | Buy | PARATEK PHARMACEUTICALS INC | $7,821,000 | +24.3% | 1,609,398 | +74.4% | 1.64% | +45.2% |
EDAP | EDAP TMS S Asponsored adr | $7,709,000 | -10.0% | 1,208,250 | 0.0% | 1.62% | +5.1% | |
PBYI | Sell | PUMA BIOTECHNOLOGY INC | $6,059,000 | -40.8% | 864,427 | -22.4% | 1.27% | -30.8% |
AVYA | AVAYA HLDGS CORPcall | $5,937,000 | -26.4% | 300,000 | 0.0% | 1.25% | -14.0% | |
AMSC | New | AMERICAN SUPERCONDUCTOR CORP | $5,766,000 | – | 395,487 | +100.0% | 1.21% | – |
FKWL | FRANKLIN WIRELESS CORP | $5,663,000 | -23.5% | 780,000 | 0.0% | 1.19% | -10.7% | |
CYBE | Sell | CYBEROPTICS CORP | $4,147,000 | -77.3% | 116,566 | -73.8% | 0.87% | -73.5% |
MYO | New | MYOMO INC | $4,139,000 | – | 348,125 | +100.0% | 0.87% | – |
RFIL | RF INDS LTD | $4,035,000 | +9.2% | 495,037 | 0.0% | 0.85% | +27.7% | |
WTT | Buy | WIRELESS TELECOM GROUP INC | $3,866,000 | -12.1% | 1,867,639 | +72.9% | 0.81% | +2.7% |
RNAZ | New | TRANSCODE THERAPEUTICS INC | $3,798,000 | – | 1,270,500 | +100.0% | 0.80% | – |
BKTI | BK TECHNOLOGIES CORPORATION | $3,786,000 | -10.3% | 1,340,000 | 0.0% | 0.80% | +4.7% | |
ALNA | ALLENA PHARMACEUTICALS | $3,608,000 | -30.6% | 4,000,000 | 0.0% | 0.76% | -18.9% | |
BWAY | Sell | BRAINSWAY LTDsponsored ads | $3,549,000 | -54.2% | 440,301 | -42.1% | 0.75% | -46.6% |
HTGM | HTG MOLECULAR DIAGNOSTICS IN | $3,494,000 | -1.7% | 612,000 | 0.0% | 0.74% | +14.8% | |
PCSA | PROCESSA PHARMACEUTICALS INC | $3,317,000 | +4.6% | 387,097 | 0.0% | 0.70% | +22.2% | |
ASYS | New | AMTECH SYS INC | $3,121,000 | – | 273,100 | +100.0% | 0.66% | – |
DAIO | DATA I O CORP | $2,731,000 | -4.1% | 418,310 | 0.0% | 0.57% | +11.9% | |
MDNA | MEDICENNA THERAPEUTICS CORP | $2,544,000 | -8.1% | 915,000 | 0.0% | 0.54% | +7.4% | |
ACTG | New | ACACIA RESH CORP | $2,464,000 | – | 362,906 | +100.0% | 0.52% | – |
CYTH | New | CYCLO THERAPEUTICS INCcall | $2,363,000 | – | 350,000 | +100.0% | 0.50% | – |
EVOK | EVOKE PHARMA INC | $2,211,000 | -5.1% | 1,701,185 | 0.0% | 0.46% | +10.7% | |
IDEAL PWR INC | $2,197,000 | +19.7% | 144,347 | 0.0% | 0.46% | +40.0% | ||
ALIMERA SCIENCES INC | $2,115,000 | -53.6% | 501,025 | 0.0% | 0.44% | -45.8% | ||
ANVS | Sell | ANNOVIS BIO INC | $2,110,000 | -80.5% | 66,469 | -47.4% | 0.44% | -77.2% |
NLSPW | NLS PHARMACEUTICS LTDcall | $2,069,000 | +137.3% | 827,921 | 0.0% | 0.44% | +177.1% | |
YTEN | YIELD10 BIOSCIENCE INC | $2,049,000 | -29.8% | 342,000 | 0.0% | 0.43% | -17.9% | |
ONDS | Sell | ONDAS HLDGS INC | $1,898,000 | -74.9% | 207,070 | -78.3% | 0.40% | -70.7% |
SCYX | Sell | SCYNEXIS INC | $1,819,000 | -83.3% | 343,126 | -76.8% | 0.38% | -80.4% |
NUWE | New | NUWELLIS INC | $1,671,000 | – | 760,000 | +100.0% | 0.35% | – |
New | DERMATA THERAPEUTICS INCcall | $786,000 | – | 175,000 | +100.0% | 0.16% | – | |
New | DERMATA THERAPEUTICS INC | $786,000 | – | 175,000 | +100.0% | 0.16% | – | |
ARDS | Sell | ARIDIS PHARMACEUTICALS INC | $554,000 | -83.4% | 150,591 | -67.2% | 0.12% | -80.5% |
PETV | New | PETVIVO HLDGS INCcall | $270,000 | – | 100,000 | +100.0% | 0.06% | – |
PETV | New | PETVIVO HLDGS INC | $135,000 | – | 50,000 | +100.0% | 0.03% | – |
HSDT | Exit | HELIUS MED TECHNOLOGIES INC | $0 | – | -101,214 | -100.0% | -0.31% | – |
CYTHW | Exit | CYCLO THERAPEUTICS INCcall | $0 | – | -350,000 | -100.0% | -0.32% | – |
SLRX | Exit | SALARIUS PHARMACEUTICALS INC | $0 | – | -1,800,000 | -100.0% | -0.34% | – |
HJLI | Exit | HANCOCK JAFFE LABORATORIES I | $0 | – | -346,885 | -100.0% | -0.43% | – |
SNPX | Exit | SYNAPTOGENIX INC | $0 | – | -316,945 | -100.0% | -0.51% | – |
ICLN | Exit | ISHARES TRput | $0 | – | -160,000 | -100.0% | -0.68% | – |
AVYA | Exit | AVAYA HLDGS CORP | $0 | – | -360,000 | -100.0% | -1.74% | – |
ASPN | Exit | ASPEN AEROGELS INC | $0 | – | -655,819 | -100.0% | -3.53% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AVIAT NETWORKS INC | 12 | Q3 2023 | 6.8% |
SCPHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
THERATECHNOLOGIES INC | 11 | Q2 2023 | 2.9% |
FRANKLIN WIRELESS CORP | 11 | Q3 2023 | 2.9% |
IDEAL PWR INC | 11 | Q3 2023 | 2.5% |
MEDICENNA THERAPEUTICS CORP | 11 | Q3 2023 | 1.1% |
PARATEK PHARMACEUTICALS INC | 10 | Q1 2023 | 3.2% |
LIGHTPATH TECHNOLOGIES INC | 10 | Q3 2023 | 3.0% |
MYOMO INC | 10 | Q3 2023 | 1.3% |
DZS INC | 9 | Q1 2023 | 7.5% |
View AIGH Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Bridgeline Digital, Inc. | May 21, 2021 | 627,419 | 9.7% |
View AIGH Capital Management LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-15 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-12 |
View AIGH Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.